ABUS vs UAL · P/E 5.4, rev $6.2M vs P/E 10, rev $57.06B
Arbutus Biopharma Corp (ABUS) versus United Airlines Holdings Inc (UAL) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
United Airlines Holdings Inc (UAL) is a airlines company listed on NASDAQ. It is led by Scott Kirby.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported UAL revenue for 2024-12-31 was $57.06B. Net income was $3.15B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
Not investment advice. Open the ABUS and UAL stock pages for the full models.
Not investment advice.